The Effect of Oral Glucosamine Supplementation on Young Adults Experiencing Mild, Undiagnosed Knee Pain.

Not Applicable

Recruiting

• Conditions: ndiagnosed knee pain; Undiagnosed knee pain; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12611000168954
• Lead Sponsor: Dr Jim Kiatos

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

people experiencing regular, mild, undiagnosed knee pain
- knee pain must be experienced at least once a week

Exclusion Criteria

- pregnancy
- breast feeding mothers
- previous diagnosis of a meniscal (knee cartilage) or ligamentous knee injury
- previous history of knee surgery,
-allergies to seafood, glucosamine, shark cartilage, chondroitin or Dimethyl sulphone
- allergies to maltodextrin wheat, corn, potatoes and other foods high in starch
- celiac disease
- participants who are currently taking containing glucosamine sulphate or have taken products containing glucosamine sulphate in the last 8 weeks
- cancer sufferers
- failure to provide written consent
- Diabetes Mellitus

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Knee Injury and Osteoarthritis Outcome Score (KOOS)will be used to assess activities of daily living, joint function and frequency of pain.[Participants will be required to complete the KOOS questionnaire, which takes about 5-10 minutes to complete, on days 1, 7, 14, 21, 28, 35, 42, 49 and 56 of the trial.];The Visual Analogue Scale (VAS): A simple outcome measure that uses a line with no pain at one end and pain at its very worst at the other end. Participants will be required to mark a cross at the point they feel best represents their pain on that day.[Participants will complete the VAS on days 1, 7, 14, 21, 28, 35, 42, 49 and 56 of the trial.];The participants will be required to keep a daily log of their medication usage, physical activity and any form of treatment they may receive. A treatment could be considered any visit to their local general practitioner, osteopath, physiotherapist, and any other form of manual therapy.[Daily entries from baseline for 8 weeks.]

Secondary Outcome Measures

Name	Time	Method
The Marx Activity Scale: The outcomes will reveal each patient's level of physical activity, an important factor that will be used later when analysing results.[Participants will be required to fill out this activity scale on day 1 of supplementation, prior to the consumption of the active ingredient or placebo];The Medical Outcomes Study 36-Item Short Form (SF-36) is a generic instrument that assesses eight health concepts and may detect unforeseen effects of the interventions used.[Participants will be required to complete the SF-36 on days 1, 28 and 56 of the trial.]